Buy Original Gonadorelin

Original gonadorelin is a synthetic decapeptide identical in amino acid sequence to native gonadotropin-releasing hormone (GnRH). PX1 Research provides analytical-grade gonadorelin strictly for in vitro and laboratory research applications requiring verified chemical sequence, precise molarity, and lot-specific purity controls.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Original gonadorelin is a synthetic decapeptide identical in amino acid sequence to native gonadotropin-releasing hormone (GnRH). PX1 Research provides analytical-grade gonadorelin strictly for in vitro and laboratory research applications requiring verified chemical sequence, precise molarity, and lot-specific purity controls.

Reviewed by PX1 Research scientific team

Key takeaways

  • Researchers seeking to buy original gonadorelin must source high-purity, laboratory-grade synthetic gonadotropin-releasing hormone (GnRH) manufactured under strict analytical controls.
  • Gonadorelin is a linear decapeptide with the primary amino acid sequence Pyroglutamyl-Histidyl-Tryptophyl-Seryl-Tyrosyl-Glycyl-Leucyl-Arginyl-Prolyl-Glycine amide (Pyro-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2).
  • In preclinical model systems, gonadorelin functions as a high-affinity agonist at the GnRH receptor (GnRHR), a seven-transmembrane G-protein-coupled receptor primarily expressed on pituitary gonadotroph cells.
  • Published literature documenting the use of original gonadorelin spans several decades of endocrine investigation.

Direct Overview: Sourcing Authentic Gonadorelin for In Vitro Research

Researchers seeking to buy original gonadorelin must source high-purity, laboratory-grade synthetic gonadotropin-releasing hormone (GnRH) manufactured under strict analytical controls. Original gonadorelin is a native-sequence decapeptide supplied for in vitro assaying, receptor binding studies, and preclinical endocrine signaling research. PX1 Research supplies verified, USA-manufactured gonadorelin with lot-specific HPLC/MS Certificates of Analysis and comprehensive endotoxin testing.

When purchasing compounds for cellular assays or animal models, sequence integrity and the absence of truncation sequences are essential to ensure experimental reproducibility. Non-authentic or lower-tier preparations often contain peptide fragments, high residual trifluoroacetic acid (TFA), or bacterial endotoxins that invalidate receptor binding kinetics and cell culture viability.

To maintain rigorous scientific standards, PX1 Research tests every batch of our gonadorelin research peptide using reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS) inside an ISO 17025 accredited laboratory facility.

Structural Chemistry and Molecular Specifications of Synthetic Gonadorelin

Gonadorelin is a linear decapeptide with the primary amino acid sequence Pyroglutamyl-Histidyl-Tryptophyl-Seryl-Tyrosyl-Glycyl-Leucyl-Arginyl-Prolyl-Glycine amide (Pyro-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2). It possesses a molecular formula of C55H75N17O13 and a theoretical molecular weight of approximately 1182.3 g/mol.

The N-terminal pyroglutamic acid modification and C-terminal glycinamide are key structural features that preserve enzymatic stability and receptor recognition capacity. Unlike modified synthetic analogs designed for extended half-lives, original gonadorelin retains the exact sequence of native endogenous GnRH, making it the primary standard for physiological neuroendocrine research models.

In synthesis, solid-phase peptide synthesis (SPPS) techniques must be carefully optimized to prevent racemization of histidine and tryptophan residues. Downstream purification via preparatory HPLC isolates the full-length 10-mer peptide from deletion sequences, yielding a dry lyophilized cake suitable for precise volumetric reconstitution in analytical protocols.

Hypothalamic-Pituitary-Gonadal (HPG) Signaling Kinetics in Preclinical Models

In preclinical model systems, gonadorelin functions as a high-affinity agonist at the GnRH receptor (GnRHR), a seven-transmembrane G-protein-coupled receptor primarily expressed on pituitary gonadotroph cells. Binding to GnRHR initiates signal transduction via the Gq/11 protein pathway, stimulating phospholipase C (PLC) activity, inositol trisphosphate (IP3) generation, and intracellular calcium mobilization.

In vitro data indicate that pulsatile exposure to native gonadorelin leads to the downstream synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In contrast, continuous non-pulsatile exposure leads to GnRHR desensitization, receptor internalization, and subsequent down-regulation of gonadotropin gene transcription.

Researchers studying the neuroendocrine control of reproduction utilize gonadorelin to explore these concentration-dependent signaling dynamics, mapping signal transduction cascades, MAPK pathway activation, and feedback mechanisms within isolated pituitary tissue cultures or rodent models.

Preclinical Literature and In Vitro Findings

Published literature documenting the use of original gonadorelin spans several decades of endocrine investigation. Early studies established its role in clarifying the differential release rates of LH and FSH from anterior pituitary explants. By controlling administration frequency in perfusion chambers, investigators observed that high-frequency pulsatility preferentially elevates LH release, whereas lower-frequency pulses favor FSH transcription.

Preclinical studies suggest that gonadorelin interaction with extra-pituitary receptors may also play a regulatory role in non-reproductive tissues. Investigators exploring peripheral GnRHR expression have utilized gonadorelin in cell cultures derived from human reproductive tract tissue, renal carcinomas, and neuronal lineages to quantify local antiproliferative or signaling effects.

Furthermore, research involving non-human primates and rodent species has demonstrated how acute gonadorelin administration impacts the downstream secretion of gonadal steroids, providing a reliable tool for assessing pituitary reserve capacity in animal models of endocrine disruption.

Comparative Analysis: Gonadorelin vs. Modified GnRH Agonists

When designing GnRHR signaling experiments, researchers often evaluate native gonadorelin alongside stabilized synthetic analogs to contrast receptor kinetics and enzymatic degradation profiles. Native original gonadorelin possesses a brief biological half-life in physiological media (typically 2 to 8 minutes) due to rapid cleavage by neutral endopeptidases and post-proline cleaving enzymes.

In contrast, substituted analogs like triptorelin incorporate D-amino acid substitutions at position 6 (such as D-Tryptophan), which resist enzymatic hydrolysis and increase binding affinity to the GnRHR by several orders of magnitude. Similarly, compounds such as leuprolide and buserelin incorporate C-terminal ethylamide modifications alongside position-6 substitutions, resulting in prolonged receptor occupancy and rapid axis suppression.

While non-native analogs are preferred for sustained desensitization models, researchers require original native-sequence gonadorelin when biological fidelity to endogenous GnRH signaling, rapid clearance, or precise pulsatile mimicry is necessary. Comparing native sequences against modified analogs allows laboratories to map precise structure-activity relationships across the full spectrum of GnRH agonists.

Quality Standards for Authenticating Original Gonadorelin

Due to the sensitivity of receptor binding assays, evaluating peptide supplier purity is critical. When searching to buy original gonadorelin, investigators should verify that the product is supported by lot-specific analytical data rather than representative stock documentation.

Key quality parameters for authentic research-grade gonadorelin include:

- **Chemical Purity (RP-HPLC):** Must demonstrate a main peak area of greater than or equal to 98.0%, confirming the absence of significant truncation peptides or diastereomeric impurities.

- **Mass Identification (ESI-MS):** Must confirm a monoisotopic or average mass corresponding precisely to 1182.3 Da, ensuring sequence authenticity without unintended side-chain protecting group retention.

- **Endotoxin Content (LAL Assay):** High-grade cell culture and preclinical formulations must maintain endotoxin levels below 0.05 EU/mg to prevent inflammatory cytokine activation in cell cultures or animal subjects.

- **Residual TFA Management:** Trifluoroacetic acid used during cleavage must be reduced through counter-ion exchange or extended lyophilization to prevent cytotoxic interference in sensitive cell lines.

Laboratory Reconstitution and Solution Stability Protocols

Original gonadorelin is supplied as a sterile-filtered, lyophilized white powder under an inert gas atmosphere. To preserve structural integrity prior to experimental use, peptide vials should be stored unopened at -20°C or -80°C in a desiccated environment.

For reconstitution, laboratories should utilize sterile, preservative-free Bacteriostatic Water, Sterile Water for Injection, or phosphate-buffered saline (PBS, pH 7.4) depending on the intended assay environment. Researchers can reference our peptide reconstitution calculator to determine accurate liquid-to-mass volumetric ratios for targeted micromolar or nanomolar concentration curves.

Once reconstituted, gonadorelin solutions should be split into single-use aliquots in polypropylene microcentrifuge tubes to prevent degradation caused by repeated freeze-thaw cycles. Diluted liquid solutions are stable at 2°C to 8°C for short-term evaluation (up to 7 days), while long-term storage of aliquots requires temperatures of -20°C or colder.

COA Verification and Analytical Metrics (HPLC & ESI-MS)

PX1 Research provides fully transparent, batch-traceable testing documentation for every compound available across our catalog of research peptides. A valid Certificate of Analysis for original gonadorelin displays the exact chromatogram generated during RP-HPLC evaluation.

The retention time of the primary peak must match established reference standards under standardized gradient elution conditions (typically water/acetonitrile containing 0.1% TFA). Accompanying mass spectrometry data must illustrate clean m/z ion signals corresponding to the singly charged [M+H]+ or doubly charged [M+2H]2+ species without secondary degradation peaks.

By enforcing these verification standards across every production batch, PX1 Research eliminates chemical ambiguity, providing research institutions with reliable materials for quantitative neuroendocrine assays. Further technical documentation can be explored in our centralized research library.

Sourcing USA-Manufactured Gonadorelin from PX1 Research

PX1 Research is an established USA supplier dedicated exclusively to laboratory accounts, university researchers, and independent scientific facilities. All peptides offered are synthesized in state-of-the-art GMP-compliant manufacturing facilities and analyzed by independent ISO 17025 accredited testing laboratories.

Orders placed before 3:00 PM EST Monday through Friday ship same-day from our primary distribution hubs in California and Arizona. Each shipment is packaged to safeguard peptide stability during transit, utilizing temp-monitored cold packing when required by compound sensitivity.

Academic institutions and high-volume laboratories seeking specialized batch sizes or custom synthesis protocols can apply for expanded purchasing options via our wholesale portal. All materials supplied by PX1 Research are strictly designated for in vitro, analytical, and preclinical research applications.

Frequently Asked Questions

What is original gonadorelin and how is it defined?

Original gonadorelin is a synthetic decapeptide identical in amino acid sequence to natural hypothalamic gonadotropin-releasing hormone (GnRH). It is utilized in laboratory settings to study HPG axis activation and receptor binding kinetics.

How does PX1 Research verify the purity of gonadorelin?

PX1 Research verifies every lot through an independent ISO 17025 accredited laboratory using reverse-phase HPLC to confirm ≥98% chemical purity, ESI-MS mass spectrometry to confirm exact molecular weight, and LAL assays to monitor endotoxin limits.

How does original gonadorelin differ from synthetic GnRH analogs like triptorelin?

Original gonadorelin matches the native human GnRH sequence and has a rapid enzymatic half-life. Analogs like triptorelin or leuprolide contain D-amino acid substitutions that dramatically increase receptor binding affinity and resistance to enzymatic cleavage.

What is the recommended reconstitution medium for gonadorelin in cell assays?

For cell culture assays, sterile phosphate-buffered saline (PBS, pH 7.4) or sterile water is typically used. For multi-use laboratory stock solutions, bacteriostatic water containing 0.9% benzyl alcohol may be utilized to prevent microbial growth.

What are the storage requirements for lyophilized gonadorelin powder?

Lyophilized gonadorelin should be stored at -20°C or -80°C in a dry, dark environment. Sealed vials remain stable for up to 24 months under controlled freezer conditions.

What are the endotoxin specifications for PX1 Research gonadorelin?

PX1 Research requires endotoxin levels to test below 0.05 EU/mg via Limulus Amebocyte Lysate (LAL) testing, preventing confounding cellular inflammation during sensitive in vitro assays.

Can gonadorelin be used for human administration or clinical therapy?

No. All products sold by PX1 Research, including gonadorelin, are strictly intended for laboratory research use only (RUO) and in vitro experimentation. They are never for human or veterinary medical use.

Where does PX1 Research ship gonadorelin orders from?

PX1 Research ships directly from facilities in California and Arizona, offering same-day dispatch for orders placed before 3:00 PM EST Monday through Friday.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.